Breaking News

Patients with type 2 diabetes and moderate cardiovascular risk had a higher rate of major heart-related events when treated with sulfonylureas.

This episode highlights how being intentional about adding value strengthens relationships and shapes effective leadership in everyday situations.

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Between discrepancies in its definition and financial pressures impacting sustainability, Michael Murphy, PharmD, MBA, joined to discuss the increasingly prominent impacts of pharmacy deserts.

After the certification of a new stroke center in respective communities, researchers compared the stroke outcomes of Black patients with those of White patients.

Since the COVID-19 pandemic, pharmacists are reevaluating career paths and calling for greater flexibility, support, and opportunities for professional growth.